Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,252.80
(
-1.87%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
79,066.68
(
0.01%
)
News Focus
News Focus
Post# of 257578
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

investorgold2002

Send PM Follow Ignore
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

investorgold2002

Re: DewDiligence post# 121505

Sunday, 06/12/2011 5:24:00 PM

Sunday, June 12, 2011 5:24:00 PM

Post# of 257578
thanks dew informative post..
I am not sure I agree with your characterization of "legacy business" that wheeler was talking about.

you said the below.

"but rather their branded biologics approved via the ordinary BLA pathway. For obvious reasons, companies that have large sales from branded biologics do not want MNTA’s biogenerics to succeed. "
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today